Demographic | Cohort characteristics |
---|---|
Gender | Male 35 (70%) |
Age (mean; range) | 72.68 (55-88) |
COPD status | |
• None | 2 (4%) |
• Mild (FEV1 ≥ 80% predicted) | 9 (18%) |
• Moderate (FEV1 50-80% predicted) | 17 (34%) |
• Severe (FEV1 30-50% predicted) | 19 (38%) |
• Very severe (FEV1 < 30% predicted) | 3 (6%) |
On optimal inhalers at initial review (n = 46) | 21 (45.7%) |
Smoking status | |
• Current | 20 (40%) |
• Ex | 25 (50%) |
• Never | 3 (6%) |
• Not recorded | 2 (4%) |
Baseline FEV1 (ml) (mean; IQR) | 1,385 (880-1730) |
Baseline FEV1 (% predicted) (mean; IQR) | 59.5% (35.8-74.8%) |
Baseline DLCO (% predicted) (mean; IQR) (n = 45) | 54.6% (42-66%) |
Self-reported baseline exercise tolerance (m) (mean; IQR) (n = 28) | 254.6 (31.3-262.5) |
Baseline MRC dyspnoea score (mean; IQR) (n = 43) | 3.74 (3-5) |